Facebook
X
LinkedIn
ForwardPulse: Leaping into Lipoprotein(a)
This presentation will increase pharmacist knowledge on the role of lipid-lowering agents in lipoprotein(a) and introduce emerging targeted treatment options that are currently being studied.
Target Audience
Pharmacist
Learning Objectives
1. Define lipoprotein(a), explain its metabolism in the body, and identify the mechanisms by which Lp(a) elevates the risk of atherosclerotic cardiovascular disease.
2. Discuss primary literature to assess the role of current lipid-lowering agents' effect on lipoprotein(a) levels and cardiovascular events.
3. Describe the current role of lipoprotein(a) testing and emerging targeted treatment options in clinical practice.
Additional Information
| Attachment | Size |
|---|---|
 GK Disclosure slides_Grace Kim.pdf | 250.41 KB |
This presentation will increase pharmacist knowledge on the role of lipid-lowering agents in lipoprotein(a) and introduce emerging targeted treatment options that are currently being studied.
Grace Kim, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.